Correlation Between PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between PROSIEBENSAT1 MEDIADR4 and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PROSIEBENSAT1 MEDIADR4/ with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals.

Diversification Opportunities for PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals

-0.18

Correlation Coefficient

PROSIEBENSAT1 MEDIADR4/  Vertex Pharmaceuticals

Good diversification

The 3 months correlation between PROSIEBENSAT1 and Vertex is -0.18. Overlapping area represents the amount of risk that can be diversified away by holding PROSIEBENSAT1 MEDIADR4 and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and PROSIEBENSAT1 MEDIADR4/ is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PROSIEBENSAT1 MEDIADR4 are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of PROSIEBENSAT1 MEDIADR4/ i.e., PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals

Assuming the 90 days trading horizon PROSIEBENSAT1 MEDIADR4 is expected to under-perform the Vertex Pharmaceuticals. In addition to that, PROSIEBENSAT1 MEDIADR4/ is 1.2 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about -0.07 of its total potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about -0.04 per unit of volatility. If you would invest  44,115  in Vertex Pharmaceuticals Incorporated on September 26, 2024 and sell it today you would lose (5,815) from holding Vertex Pharmaceuticals Incorporated or give up 13.18% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

PROSIEBENSAT1 MEDIADR4  vs.  Vertex Pharmaceuticals Incorpo

PROSIEBENSAT1 MEDIADR4/

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days PROSIEBENSAT1 MEDIADR4 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's primary indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Vertex Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Vertex Pharmaceuticals Incorporated has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals

The main advantage of trading using opposite PROSIEBENSAT1 MEDIADR4/ and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PROSIEBENSAT1 MEDIADR4/ position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind PROSIEBENSAT1 MEDIADR4 and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.